Published by
Reuters
Reuters
The U.S. Food and Drug Administration (FDA) said on Tuesday it sent warning letters to twelve companies for selling certain over-the-counter (OTC) skin lightening products which have not been approved by the agency and pose safety risks. The products from companies including M & M Beauty and Wellness, Ultimark Products and Genomma Lab USA contain hydroquinone, a depigmentation agent used in skin lightening creams which has come under the FDA’s scrutiny over safety concerns. There is currently only one drug, Tri-Luma, approved by the FDA which contains hydroquinone, the agency said. The Tri-Lum…